IP Library Granted Patent US 6,936,601
Granted Patent B2
US 6,936,601 · App. 10/224,224 · Granted Aug 30, 2005

Compositions for treating pain

Assignee: Eli Lilly and Company
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,936,601
App. No.
10/224,224
Granted
Aug 30, 2005
Kind
B2
Abstract

The present invention provides compositions for treating pain using an atypical antipsychotic compound that is seroquel in combination with another Drug Used in the Treatment of Pain.

Claims (10)

1. A pharmaceutical composition comprising an atypical antipsychotic which is seroquel or a pharmaceutically acceptable salt or solvate thereof; and one or more Drug Used in the Treatment of Pain in a weight ratio of atypical antipsychotic to another Drug Used in the Treatment of Pain from about one part atypical antipsychotic to from about one (1) to about one thousand (1000) parts Drug Used in the Treatment of Pain.

2. A pharmaceutical composition comprising an atypical antipsychotic which is seroquel or a pharmaceutically acceptable salt or solvate thereof; and one or more Drug Used in the Treatment of Pain in a weight ratio of atypical antipsychotic to another Drug Used in the Treatment of Pain from about one part atypical antipsychotic to from about one (1) to about one hundred (100) parts Drug Used in the Treatment of Pain.

3. A pharmaceutical composition according to claim 2 wherein the Drug Used in the Treatment of Pain is selected from the group consisting of aspirin, ibuprophen, acetaminophen, indomethacin, Tylenol #3, tricyclic antidepressants, anticonvulsants, serotonin reuptake inhibitors, mixed serotonin-norepinephrine reuptake inhibitors, serotonin receptor agonists and antagonists, cholinergic analgesics, adrenergic agents, and neurokinin antagonists.

4. A pharmaceutical composition according to claim 3 wherein the Drug Used in the Treatment of Pain is a serotonin reuptake inhibitor.

5. A pharmaceutical composition according to claim 4 wherein the serotonin reuptake inhibitor is fluoxetine.

6. A pharmaceutical composition according to claim 4 wherein the serotonin reuptake inhibitor is paroxetine.

7. A pharmaceutical composition according to claim 4 wherein the serotonin reuptake inhibitor is sertraline.

8. A pharmaceutical composition according to claim 3 wherein the Drug Used in the Treatment of Pain is a mixed serotonin-norepinephrine reuptake inhibitor.

9. A pharmaceutical composition according to claim 8 wherein the mixed serotonin-norepinephrine reuptake inhibitor is venlafaxine.

10. A pharmaceutical composition according to claim 8 wherein the mixed serotonin-norepinephrine reuptake inhibitor is duloxetine.

Continuity (4)
Division 0949804700 · Feb 4, 2000
Continuation 0882345800 · Mar 24, 1997
Provisional Application 6001415200 · Mar 25, 1996
Related Publication 20030013689A1 · Jan 16, 2003